Pain News and Research

Latest Pain News and Research

Palliative care can reduce pain and other distressing symptoms

Palliative care can reduce pain and other distressing symptoms

U.S. Court awards Teva favorable decision for generic Celebrex

U.S. Court awards Teva favorable decision for generic Celebrex

FDA grants Angiochem’s ANG1005 fast track and orphan drug designation for treatment of glioblastoma multiforme

FDA grants Angiochem’s ANG1005 fast track and orphan drug designation for treatment of glioblastoma multiforme

Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients with brain metastases

Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients with brain metastases

Internalized stigma negatively linked with poor self-esteem and personal control of pain

Internalized stigma negatively linked with poor self-esteem and personal control of pain

Women with metastatic breast cancer can receive bisphosphonates less frequently and safely

Women with metastatic breast cancer can receive bisphosphonates less frequently and safely

Discontinuing statins in patients with advanced illnesses improves quality of life

Discontinuing statins in patients with advanced illnesses improves quality of life

Positive activities administered online can lead to lasting reductions in bodily pain

Positive activities administered online can lead to lasting reductions in bodily pain

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals submits safinamide NDA to FDA

Viewpoints: Michelle Obama and school lunches; more about the VA health system 'scandal'; context and caution on Medicare's physician data release

Viewpoints: Michelle Obama and school lunches; more about the VA health system 'scandal'; context and caution on Medicare's physician data release

InSightec inaugurates first centers in Shanghai

InSightec inaugurates first centers in Shanghai

Nerve block technique offers potentially speedier recovery for orthopedic surgery patients

Nerve block technique offers potentially speedier recovery for orthopedic surgery patients

Rare type of melanoma that attacks palms, soles twice likely to recur, says NYU study

Rare type of melanoma that attacks palms, soles twice likely to recur, says NYU study

Active Implants receives IDE approval to conduct NUsurface Meniscus Implant trial for knee osteoarthritis

Active Implants receives IDE approval to conduct NUsurface Meniscus Implant trial for knee osteoarthritis

Researchers investigated how emotions vary during travel and by travel mode

Researchers investigated how emotions vary during travel and by travel mode

Vibration exercise may reduce pain in individuals diagnosed with fibromyalgia

Vibration exercise may reduce pain in individuals diagnosed with fibromyalgia

Study explores how ACA empowers CRNAs to make anesthesia services more accessible to patients

Study explores how ACA empowers CRNAs to make anesthesia services more accessible to patients

Synexus starts new state of art clinical trial centre in Bochum, Germany

Synexus starts new state of art clinical trial centre in Bochum, Germany

ALOXI injection receives FDA approval for prevention of nausea, vomiting associated with cancer chemotherapy

ALOXI injection receives FDA approval for prevention of nausea, vomiting associated with cancer chemotherapy

Initial biopsy with epigenetic test rules out prostate cancer up to 88%

Initial biopsy with epigenetic test rules out prostate cancer up to 88%

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.